pharmaceutical investing Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
pharmaceutical investing Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
pharmaceutical investing Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
pharmaceutical investing Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
pharmaceutical investing Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
pharmaceutical investing Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
pharmaceutical investing Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
pharmaceutical investing Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality - Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
pharmaceutical investing Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company's Board of Directors
pharmaceutical investing Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
pharmaceutical investing Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
pharmaceutical investing Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
Homerun Resources Inc. Advances Solar Glass Project Financing with Letter of Intent from Leading European Project Finance Bank for up to 170 Million Euros
Transition Metals Commences 2026 Exploration Program at Pike Warden Epithermal Gold-Silver and Porphyry Copper Project, Yukon
Infill Drilling Significantly Widens and Extends Near Surface Gold Mineralisation at Gemdale Gold's Pontio Gold Project, Finland
SAGA Metals Reports Assays from R-0055 to R-0057 with Intercepts Including 53.72% Fe2O3, 8.24% TiO2, 0.377% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador
